SCHEDULE 13G/A: Investment Firms Disclose Significant Stake in National Research Corp, Boosting Combined Ownership to 12.92%

Kayne Anderson Rudnick Investment Management, LLC, along with Virtus Investment Advisers, LLC and Virtus Equity Trust, have disclosed a combined beneficial ownership of 12.92% in National Research Corp common stock.

Summary

• Kayne Anderson Rudnick Investment Management, LLC (KAR) beneficially owns 2,964,081 shares of National Research Corp common stock, representing 12.92% of the class.
• Virtus Investment Advisers, LLC (VIA) beneficially owns 2,047,353 shares, representing 8.92% of the common stock. These shares are also included in the amounts reported by Kayne Anderson Rudnick Investment Management, LLC.
• Virtus Equity Trust on behalf of Virtus KAR Small Cap Growth Fund (VET) beneficially owns 2,008,009 shares, representing 8.75% of the common stock. These shares are also included in the amounts reported by Virtus Investment Advisers, LLC.
• KAR holds sole voting power over 449,090 shares and shared voting power over 2,484,023 shares, with sole dispositive power over 480,058 shares and shared dispositive power over 2,484,023 shares.
• VIA and VET primarily hold shared voting and dispositive power over their respective beneficial ownership amounts, with no sole voting or dispositive power reported.

Sentiment

Score: 7

Explanation: The filing indicates a significant and passive institutional investment by well-known firms, which is generally viewed positively as a vote of confidence in the issuer. The 'Amendment No. 11' suggests a long-standing or evolving position, but without prior filings, the exact change (increase/decrease) isn't clear from this document alone. However, a large stake by an investment advisor is typically positive.

Positives

• The disclosure of a significant beneficial ownership stake (12.92%) by established investment firms like Kayne Anderson Rudnick and Virtus Investment Advisers can signal institutional confidence in National Research Corp's long-term prospects.
• The passive nature of the filing (Schedule 13G) indicates that the shares were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of the issuer.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding the issuer's future outlook.

Industry Context

This filing indicates a significant institutional investment in National Research Corp, a company likely operating in the healthcare or market research sector, given its name. Such investments are common in the industry as fund managers seek exposure to specific market segments and can be viewed as a vote of confidence in the company's position within its market.

Related Party Transactions

• Kayne Anderson Rudnick Investment Management, LLC, Virtus Investment Advisers, LLC, and Virtus Equity Trust entered into a joint filing agreement for this Schedule 13G, acknowledging shared responsibility for the filing's accuracy concerning their respective information.

Stakeholder Impact

• Shareholders may view the significant institutional ownership as a positive signal of investor confidence and potential stability in the stock.
• The filing does not directly impact employees, customers, suppliers, or creditors of National Research Corp, as it pertains solely to ownership structure.

Key Dates

Keywords

National Research Corp, NRC, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, Kayne Anderson Rudnick Investment Management, Virtus Investment Advisers, Virtus Equity Trust, Investment Adviser